Filing Details

Accession Number:
0001666071-20-000028
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-18 20:43:58
Reporting Period:
2020-02-18
Accepted Time:
2020-02-18 20:43:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204015 Kirk Somers C/O Cardlytics, Inc.
675 Ponce De Leon Avenue Ne, Suite 6000
Atlanta GA 30308
Chief Legal & Privacy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-18 1,562 $30.44 76,455 No 4 M Direct
Common Stock Disposition 2020-02-18 2,000 $98.12 74,455 No 4 S Direct
Common Stock Disposition 2020-02-18 2,781 $100.00 71,674 No 4 S Direct
Common Stock Disposition 2020-02-18 781 $102.41 70,893 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2020-02-18 1,562 $0.00 1,562 $30.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,938 2027-07-07 No 4 M Direct
Footnotes
  1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019.
  2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $102.40 to $102.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
  3. This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.